TFC

TFC Therapeutics Launches to Advance Novel Platform and Technologies in Cancer Biology

Retrieved on: 
Thursday, August 17, 2023
Columbia University, Metastasis, Pfizer, Physician, Cancer, Hope, Innovation, ARCH Venture Partners, MBA, Cell, TFC, TMH, Advisory board, Doctor of Philosophy, Assistant, ARCH, Global Health, Patient, Edward, Columbia University Vagelos College of Physicians and Surgeons, Drug discovery, Bill, Therapy, Recurrence, Alexandria Real Estate Equities, Pharmaceutical industry, Pomona College, Economics, Surgeon, Medicine

NEW YORK, Aug. 17, 2023 /PRNewswire/ -- TFC Therapeutics (TFC), a biotechnology company focused on developing novel biologics to target and eliminate key drivers of cancer recurrence and metastasis, today announced a financing led by ARCH Venture Partners with participation from Breakout Ventures, Alexandria Real Estate Equities, and Alumni Ventures.  In connection with the financing, Steven Gillis, Ph.D., Managing Director at ARCH, has been appointed as Chairman of the TFC Board of Directors. 

Key Points: 
  • In connection with the financing, Steven Gillis, Ph.D., Managing Director at ARCH, has been appointed as Chairman of the TFC Board of Directors.
  • TFC has entered into an exclusive license agreement with Columbia University to develop a drug discovery platform that targets Tumor Macrophage Hybrid (TMH) cells.
  • TFC's emerging platform technologies are focused on the elimination of TMH cells, which are found in the bloodstream of patients with cancer.
  • "At TFC, we remain committed to bringing forward a new approach to treatment of cancer metastasis and relapse that will benefit patients living with cancer," said Jennifer Power, Chief Executive Officer of TFC Therapeutics.

Truist invests $17 million in the future of Charlotte and communities across North Carolina

Retrieved on: 
Thursday, August 10, 2023
President Clinton, Learning, Truist Financial, White House, NOAH, Housing, Jimmy Simpson (North Carolinian racing driver), Atrium Health, Information technology, Npower, PNC Financial Services, Research Triangle, House, Rehabilitation, Naturally, TFC, II, Organization, Truist, Acquisition, Investment, Risk, Honeywell, Small business, City, NYSE, Tar Heel, Nursing, Management

CHARLOTTE, N.C., Aug. 10, 2023 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) and Truist Foundation today announced $17 million in commitments to support affordable housing in Charlotte and career development and economic mobility programs across North Carolina.

Key Points: 
  • $1 million Truist Foundation grant to Per Scholas North Carolina to expand technology skills training in rural North Carolina.
  • $1 million Truist Foundation grant to NPower to provide technology skills and employment opportunities for military-connected individuals and underserved young adults in the Raleigh community.
  • That's why we're thrilled to be partnering with Truist Foundation for our expansion into North Carolina," said Bertina Ceccarelli, CEO of NPower.
  • Per Scholas North Carolina has seen the impact of our rural training model already, injecting more than $1.9 million back into local communities.

Truist to present at the Barclays Global Financial Services Conference

Retrieved on: 
Thursday, August 10, 2023
Webcast, Truist Financial, Truist, CHARLOTTE, Conference, NYSE, TFC, Management, Broadcasting

CHARLOTTE, N.C., Aug. 10, 2023 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) today announced that Chairman and Chief Executive Officer Bill Rogers and Chief Financial Officer Mike Maguire will present at the Barclays Global Financial Services Conference at 10:30 a.m.

Key Points: 
  • CHARLOTTE, N.C., Aug. 10, 2023 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) today announced that Chairman and Chief Executive Officer Bill Rogers and Chief Financial Officer Mike Maguire will present at the Barclays Global Financial Services Conference at 10:30 a.m.
  • ET on Monday, Sept. 11, 2023, in New York City.
  • A live audio webcast will be available the day of the event at ir.truist.com under Events & Presentations.
  • A replay of the webcast will be available on the website for 30 days.

Reproductive Endocrinologist Eric Han, M.D., Joins Texas Fertility Center San Antonio

Retrieved on: 
Tuesday, July 25, 2023
Endometriosis, Yale School of Medicine, University, Woman, Infertility, Research, Yale school, TFC, IVF, Patient, Physician, Nursing, Frustration, Yale University, British Nuclear Medicine Society, University of Connecticut School of Medicine, Birth control

San Antonio, July 25, 2023 (GLOBE NEWSWIRE) -- Texas Fertility Center (TFC) is pleased to announce that reproductive endocrinologist Eric Han, M.D., is joining its San Antonio office.

Key Points: 
  • San Antonio, July 25, 2023 (GLOBE NEWSWIRE) -- Texas Fertility Center (TFC) is pleased to announce that reproductive endocrinologist Eric Han, M.D., is joining its San Antonio office.
  • As a highly trained reproductive endocrinologist, Eric Han, M.D., provides patients with all the comprehensive services that Texas Fertility Center San Antonio offers, helping people move beyond the frustration of infertility to the joy of parenthood.
  • He says, “I’m looking forward to working with the tremendous staff, including the physicians, nurses and support staff, at Texas Fertility Center San Antonio.
  • It’s an honor and a privilege to work with this great group of people to provide the finest fertility care.”
    Eric Han, M.D., is now accepting new patients at Texas Fertility Center San Antonio.

TFC Financial Names Brian Presti as Chief Investment Officer

Retrieved on: 
Monday, July 10, 2023
Asset Management, Professional Services, Finance, Columbia University, Sustainability, CFA, The Wall Street Journal, Simon Prestigiacomo, Health, Multimedia, TFC, Kiplinger, Certification, City, Publication, Chartered Financial Analyst, News, Financial adviser

TFC Financial, an independent, fee-only financial advisory firm, has appointed Brian Presti, CFA, as its Chief Investment Officer and leader of the firm’s investment team.

Key Points: 
  • TFC Financial, an independent, fee-only financial advisory firm, has appointed Brian Presti, CFA, as its Chief Investment Officer and leader of the firm’s investment team.
  • Presti will be working closely with TFC ’s Investment Committee to make decisions on asset allocation, portfolio structure, the selection of external fund managers, and new investment opportunities.
  • View the full release here: https://www.businesswire.com/news/home/20230710555209/en/
    BRIAN PRESTI has been named Chief Investment Officer at TFC Financial, an independent, fee-only Boston investment advisor and financial planning firm.
  • TFC Financial President and CEO Renée Kwok said: “All of us at TFC are excited to welcome Brian to the team.

Advanced Gas Separation Membrane Materials Enter the Market, Reports IDTechEx

Retrieved on: 
Monday, July 10, 2023
PIMS, Carbon, Membrane, Polymer, Traction, MMM, PBI, FSC, Temperature, History, TFC, Fiber, Sewage treatment, Robeson

As decarbonization market drivers present a new growth opportunity, these advanced materials are beginning to exit the lab and enter the market.

Key Points: 
  • As decarbonization market drivers present a new growth opportunity, these advanced materials are beginning to exit the lab and enter the market.
  • Gas separation membranes have already achieved commercial adoption in multiple applications, specifically nitrogen production, hydrogen recovery, natural gas treatment, and vapor recovery.
  • There remains an extensive amount of R&D, from both academia and industry, in exploring advanced materials for gas separation membranes.
  • Gas Separation Membranes 2023-2033 ' provides a detailed independent technology appraisal for these membrane materials, including benchmarking studies, unresolved challenges, adoption roadmaps and manufacturer profiles.

Advanced Gas Separation Membrane Materials Enter the Market, Reports IDTechEx

Retrieved on: 
Monday, July 10, 2023
PIMS, Carbon, Membrane, Polymer, Traction, MMM, PBI, FSC, Temperature, History, TFC, Fiber, Sewage treatment, Robeson

As decarbonization market drivers present a new growth opportunity, these advanced materials are beginning to exit the lab and enter the market.

Key Points: 
  • As decarbonization market drivers present a new growth opportunity, these advanced materials are beginning to exit the lab and enter the market.
  • Gas separation membranes have already achieved commercial adoption in multiple applications, specifically nitrogen production, hydrogen recovery, natural gas treatment, and vapor recovery.
  • There remains an extensive amount of R&D, from both academia and industry, in exploring advanced materials for gas separation membranes.
  • Gas Separation Membranes 2023-2033 ' provides a detailed independent technology appraisal for these membrane materials, including benchmarking studies, unresolved challenges, adoption roadmaps and manufacturer profiles.

uniQure Announces Update on U.S. Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease

Retrieved on: 
Wednesday, June 21, 2023
University College London Hospitals NHS Foundation Trust, University College London, CHDI, UCL, FRCP, Central nervous system, Natural history, Depression, DSMB, Event, TMS, AFL, Neurodegenerative disease, Clinical trial, Cure, Research, Inflammation, TFC, Interest, Data monitoring committee, CAG, Back pain, SAE, Data analysis, PIN, Patient, Composite, Deep vein thrombosis, Functional capacity evaluation, CSF, Phase, Immunosuppression, Nerve, Unified, Vaccine, Pharmaceutical industry, EU

Phase I/II clinical trial of AMT-130 for the treatment of Huntington’s disease.

Key Points: 
  • Phase I/II clinical trial of AMT-130 for the treatment of Huntington’s disease.
  • Phase I/II clinical trial of AMT-130, a one-time administered investigational gene therapy for Huntington’s Disease,” stated Ricardo Dolmetsch, Ph.D., president of research and development at uniQure .
  • Phase I/II Trial of AMT-130 in Huntington’s Disease
    A total of 26 patients with early-manifest Huntington’s disease have been enrolled in the multi-center, U.S.
  • Phase I/II clinical trial concluded there are no safety concerns with either dose and recommended continuing clinical development of AMT-130.

Truist announces second-quarter 2023 earnings call details

Retrieved on: 
Tuesday, June 20, 2023
Webcast, Truist Financial, NYSE, TFC, Cryptocurrency, Broadcasting, Management

CHARLOTTE, N.C., June 20, 2023 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) will report second-quarter 2023 financial results before the market opens on Thursday, July 20, 2023.

Key Points: 
  • CHARLOTTE, N.C., June 20, 2023 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) will report second-quarter 2023 financial results before the market opens on Thursday, July 20, 2023.
  • Chairman and Chief Executive Officer Bill Rogers and Chief Financial Officer Mike Maguire will host a conference call to review the company's financial results at 8 a.m.
  • ET.
  • Investors can access the live earnings call by webcast or dial-in as follows:

David Smith named Head of Truist Mortgage

Retrieved on: 
Tuesday, June 20, 2023
Truist Financial, Small business, Insurance, Citibank, Smith, System, Dream, NYSE, TFC, Management, Real estate, Truist

CHARLOTTE, N.C., June 20, 2023 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) today announced that David Smith has been named head of Truist Mortgage. Todd Chamberlain will continue to assist with the transition and retire from Truist, effective July 31.

Key Points: 
  • CHARLOTTE, N.C., June 20, 2023 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) today announced that David Smith has been named head of Truist Mortgage.
  • Smith will lead strategy and execution for all areas of mortgage including originations, fulfillment, nationwide direct channels, correspondent, warehouse lending, and servicing for more than 1.2 million clients.
  • In his new role, Smith will report to Truist Chief Retail and Small Business Banking Officer Dontá Wilson.
  • "David's experience and accomplishments as a leader in the mortgage industry position Truist to reimagine the future of Truist Mortgage for our clients," said Chief Retail and Small Business Banking Officer Dontá Wilson.